Nicotine e-cigarettes outperform patches and gum for quitting smoking

Researchers have found that nicotine e-cigarettes help more smokers quit than traditional nicotine replacement therapies like patches and gum. A review of 14 systematic studies from 2014 to 2023 shows consistent high-quality evidence favoring nicotine vapes. The findings highlight gaps in research on long-term risks and comparisons to other treatments.

A team led by Dr. Angela Difeng Wu from the University of Oxford's Nuffield Department of Primary Care Health Sciences analyzed 14 systematic reviews on smoking cessation methods. The highest-quality studies consistently demonstrated higher quit rates with nicotine e-cigarettes compared to nicotine patches, gum, lozenges, non-nicotine e-cigarettes, and behavioral support programs alone. Lower-quality research showed more mixed results, but the strongest evidence supports nicotine e-cigarettes as more effective. The work, published in the journal Addiction, was funded by Cancer Research UK. Dr. Wu stated, 'We hope this overview and Evidence and Gap Map can lay to rest some claims that evidence is mixed regarding the impacts of nicotine e-cigarettes on smoking abstinence. In fact, the evidence is clear and consistent across all of the meta-analyses we consulted: e-cigarettes are effective at helping people stop smoking.' Researchers created an Evidence and Gap Map to identify research needs. No high-quality reviews compare nicotine e-cigarettes to cytisine, bupropion, or nicotine pouches, and evidence against varenicline comes from just one small, high-bias study. Data on serious adverse events remains uncertain, and most studies focus on high-income countries. The authors call for more research on risks and diverse populations.

Verwandte Artikel

Drug commissioner Hendrik Streeck at press conference urging ban on sweet-flavored e-cigarettes to safeguard youth from addiction.
Bild generiert von KI

Drogenbeauftragter Streeck fordert Verbot süßer Aromen in E-Zigaretten

Von KI berichtet Bild generiert von KI

Der Drogenbeauftragte der Bundesregierung, Hendrik Streeck, setzt sich für ein Verbot süßer Aromen in Elektrozigaretten ein, um Jugendliche zu schützen. Er kritisiert die Vermarktung als Anfix-Strategie und begrüßt geplante Verbote von 13 Inhaltsstoffen. Suchtforscher Heino Stöver hält die Maßnahmen jedoch für ungerechtfertigt.

Law 2354 of 2024 aims to regulate nicotine electronic systems and similar products, but its implementation faces significant delays. Two years after promulgation, key provisions like mandatory labeling and advertising bans remain unenforced. This allows uncontrolled circulation of vapes among teens, per Ministry of Justice data.

Von KI berichtet

China's State Tobacco Monopoly Administration released a draft policy on Thursday to reduce excess capacity in the e-cigarette sector and tighten enforcement of production and export standards. This follows a State Council opinion earlier this month that imposed stricter oversight on e-cigarettes and nicotine pouches.

Eine neue Studie der University of Gothenburg zeigt, dass Tirzepatid, der Wirkstoff im Diabetes- und Abnehmmedikament Mounjaro, den Alkoholkonsum und rückfallähnliches Verhalten bei Ratten und Mäusen reduziert. Dies baut auf frühere Forschung zu Semaglutid in Ozempic und Wegovy auf, das den Alkoholkonsum beim Menschen drosselt. Forscher hoffen auf ähnliche Effekte bei Patienten mit Alkoholabhängigkeit.

Von KI berichtet

A new review of clinical trials suggests that psychedelics like psilocybin are effective for treating depression but offer no advantage over traditional antidepressants. Researchers accounted for the challenge of blinding in psychedelic studies, where participants can often tell if they received the drug. The findings indicate similar outcomes when compared to unblinded antidepressant trials.

A comprehensive review of clinical trials suggests that cannabis products high in THC may provide modest, short-term relief for chronic pain, especially neuropathic types, but with notable side effects. In contrast, CBD-dominant products offer no clear advantages. Researchers call for more long-term studies to assess safety and efficacy.

Von KI berichtet

Ab April können starke Raucherinnen und Raucher zwischen 50 und 75 Jahren in Deutschland eine jährliche kostenlose Untersuchung auf Lungenkrebs erhalten. Das Angebot nutzt Niedrigdosis-Computertomographie, um den Krebs früh zu erkennen. Es richtet sich an aktive und ehemalige Raucher mit mindestens 15 Packungsjahren.

 

 

 

Diese Website verwendet Cookies

Wir verwenden Cookies für Analysen, um unsere Website zu verbessern. Lesen Sie unsere Datenschutzrichtlinie für weitere Informationen.
Ablehnen